Company intelligence
European Urology Oncology
Multiple disciplines, one goal IF: 8.5 (2025)
About European Urology Oncology
European Urology Oncology is a sister journal to European Urology and European Urology Focus, and the first official publication of the European Association of Urology fully devoted to the study of genitourinary malignancies. The journal aims to deliver high quality research while implementing a multi-disciplinary approach to incorporate Urology, Medical Oncology, Radiation Therapy, Imaging, Pathology and Basic Research with the ultimate goal of advancing research in urological oncology. European Urology Oncology includes original articles, opinion piece editorials and invited reviews covering clinical, basic and translational research and is published six times a year in electronic format. All submitted manuscripts will be peer-reviewed by a panel of experts before being considered for publication. The journal supports Open Access.
Verified activity
Signals from European Urology Oncology
8 published signals
Research & Knowledge
European Urology Oncology published a full-length randomized cohort study comparing long-term oncological outcomes of retzius-sparing versus anterior robot-assisted radical prostatectomy by Alfonso Santangelo, Firas Abdollah, Emanuele Montanari, Nicola Nicolai, Alberto Briganti, Francesco Montorsi, and Firas Abdollah.
Reported by European Urology Oncology
Research & Knowledge
European Urology Oncology published a paper titled Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future Directions by Laura Marandino, Axel Bex, and colleagues on Thursday.
Reported by European Urology Oncology
Presence & Recognition
European Urology Oncology announced that Laura Mertens has been awarded the Reviewer Recognition Award for her outstanding dedication as a reviewer.
Reported by European Urology Oncology
Research & Knowledge
European Urology Oncology published the Doublet Versus Triplet Therapy study, results from the ARON-3 study in high-volume metastatic hormone-sensitive prostate cancer patients with bone metastases by Philipp Cornelius Mandel et al.
Reported by European Urology Oncology
Research & Knowledge
European Urology Oncology published the DaBlaCa-13 Study, a five-year follow-up from a randomized controlled trial of chemoresection with intravesical mitomycin c in recurrent non-muscle-invasive bladder cancer by Søren Klingenberg et al.
Reported by European Urology Oncology
Research & Knowledge
European Urology Oncology published the AI-MIRACLE study, an AI and multi-parametric MRI study predicting clinical outcomes to neoadjuvant immunotherapy in patients with muscle-invasive bladder cancer undergoing radical cystectomy by Andrea Necchi et al.
Reported by European Urology Oncology
Research & Knowledge
European Urology Oncology published an expert commentary on best practices for FGFR3 testing in urothelial carcinoma from patient identification to result reporting by Eva M. Compérat et al.
Reported by European Urology Oncology
Research & Knowledge
European Urology Oncology published a full-length article titled Landscape of Actionable Genetic Alterations in Advanced Urothelial Carcinoma: High Prevalence but Limited Clinical Use by Maria Giulia Carta, PhD, Arndt Hartmann, Markus Eckstein, MD PhD, and Fulvia Ferrazzi.
Reported by European Urology Oncology